Gelesis is a clinical stage company developing a new category of therapy to safely treat overweight, obese and diabetic patients. The Gelesis executive and advisory team includes the world's top experts in obesity research and clinical development, former regulatory leaders, entrepreneurs and innovators in advanced materials.
Market
Obesity and Diabetes Treatment
Location
Boston,
MA,
USA
Coinvestors
Cormorant Asset Management, INVESCO Private Capital, Pritzker/Vlock Family Office